Patents by Inventor Matthew A. Firpo

Matthew A. Firpo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS AND METHODS FOR DIAGNOSIS OF EARLY STAGE PANCREATIC DUCTAL ADENOCARCINOMA
    Publication number: 20210356469
    Abstract: The present invention provides biomarker compositions and methods for the diagnosis and prognosis of PDAC. In a particular embodiment, the invention provides methods and compositions for screening, diagnosis and prognosis of early stage, asymptomatic PDAC.
    Type: Application
    Filed: August 2, 2021
    Publication date: November 18, 2021
    Inventors: Sean J. Mulvihill, Matthew A. Firpo
  • Biomarkers and methods for diagnosis of early stage pancreatic ductal adenocarcinoma
    Patent number: 11079384
    Abstract: The present invention provides biomarker compositions and methods for the diagnosis and prognosis of PDAC. In a particular embodiment, the invention provides methods and compositions for screening, diagnosis and prognosis of early stage, asymptomatic PDAC.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: August 3, 2021
    Assignee: University of Utah Research Foundation
    Inventors: Sean J. Mulvihill, Matthew A. Firpo
  • BIOMARKERS AND METHODS FOR DIAGNOSIS OF EARLY STAGE PANCREATIC DUCTAL ADENOCARCINOMA
    Publication number: 20200088733
    Abstract: The present invention provides biomarker compositions and methods for the diagnosis and prognosis of PDAC. In a particular embodiment, the invention provides methods and compositions for screening, diagnosis and prognosis of early stage, asymptomatic PDAC.
    Type: Application
    Filed: October 21, 2019
    Publication date: March 19, 2020
    Inventors: Sean J. Mulvihill, Matthew A. Firpo
  • Biomarkers and methods for diagnosis of early stage pancreatic ductal adenocarcinoma
    Patent number: 10451628
    Abstract: The present invention provides biomarker compositions and methods for the diagnosis and prognosis of PDAC. In a particular embodiment, the invention provides methods and compositions for screening, diagnosis and prognosis of early stage, asymptomatic PDAC.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: October 22, 2019
    Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Sean J. Mulvihill, Matthew A. Firpo
  • BIOMARKERS AND METHODS FOR DIAGNOSIS OF EARLY STAGE PANCREATIC DUCTAL ADENOCARCINOMA
    Publication number: 20170108502
    Abstract: The present invention provides biomarker compositions and methods for the diagnosis and prognosis of PDAC. In a particular embodiment, the invention provides methods and compositions for screening, diagnosis and prognosis of early stage, asymptomatic PDAC.
    Type: Application
    Filed: May 6, 2015
    Publication date: April 20, 2017
    Inventors: Sean J. Mulvihill, Matthew A. Firpo